adalimumab biosimilar - Stada, mAbxience
Stada: Capital Markets Day 2016 (Stada) - Oct 8, 2016 - Anticipated launch in inflammatory disease in 2019 
Anticipated biosimilar launch • Biosimilar
https://www.stada.com/fileadmin/user_upload/A_stada.de/5_Investor_Relations.de/05_Finanzpublikationen/002_CMD/2016/STADA_Capital_Markets_Day_Slegers.pdf
 
Oct 8, 2016
 
 
f7520612-6cae-43d9-9678-da25c8409b6d.jpg